Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice
Open Access
- 30 June 2011
- journal article
- research article
- Published by Springer Nature in Virology Journal
- Vol. 8 (1) , 333
Abstract
Background: The incidence of dengue, an infectious disease caused by dengue virus (DENV), has dramatically increased around the world in recent decades and is becoming a severe public health threat. However, there is currently no specific treatment for dengue fever, and licensed vaccine against dengue is not available. Vaccination with virus-like particles (VLPs) has shown considerable promise for many viral diseases, but the effect of DENV VLPs to induce specific immune responses has not been adequately investigated.Results: By optimizing the expression plasmids, recombinant VLPs of four antigenically different DENV serotypes DENV1-4 were successfully produced in 293T cells. The vaccination effect of dengue VLPs in mice showed that monovalent VLPs of each serotype stimulated specific IgG responses and potent neutralizing antibodies against homotypic virus. Tetravalent VLPs efficiently enhanced specific IgG and neutralizing antibodies against all four serotypes of DENV. Moreover, vaccination with monovalent or tetravalent VLPs resulted in the induction of specific cytotoxic T cell responses.Conclusions: Mammalian cell expressed dengue VLPs are capable to induce VLP-specific humoral and cellular immune responses in mice, and being a promising subunit vaccine candidate for prevention of dengue virus infection.Keywords
This publication has 35 references indexed in Scilit:
- The Length of and Nonhydrophobic Residues in the Transmembrane Domain of Dengue Virus Envelope Protein Are Critical for Its Retention and Assembly in the Endoplasmic ReticulumJournal of Virology, 2010
- A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infectionNature Medicine, 2010
- HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole bloodVaccine, 2005
- Virus-Like Particle (VLP) Vaccine Conferred Complete Protection against a Lethal Influenza Virus ChallengeViral Immunology, 2005
- Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai childrenThe Pediatric Infectious Disease Journal, 2004
- Inefficient Signalase Cleavage Promotes Efficient Nucleocapsid Incorporation into Budding Flavivirus MembranesJournal of Virology, 2004
- Flavivirus DNA VaccinesAnnals of the New York Academy of Sciences, 2001
- Immunogenicity of the yeast recombinant p17/p24:Ty virus-like particles (p24-VLP) in healthy volunteersVaccine, 1995
- A Live Attenuated Dengue-L Vaccine Candidate (45AZ5) Passaged In Primary Dog Kidney Cell Culture Is Attenuated And Immunogenic For HumansThe Journal of Infectious Diseases, 1994
- FLAVIVIRUS GENOME ORGANIZATION, EXPRESSION, AND REPLICATIONAnnual Review of Microbiology, 1990